Description
BLOOD DERIVATIVES SOLIRIS
First action · last action
2008-03-13 · 2008-03-13
Transactions
1
First transaction's obligation
$91,452
Base + all options value (sum of deltas)
$91,452
Extent competed
NON-COMPETITIVE DELIVERY ORDER
Other than full & open authority
FOLLOW-ON CONTRACT
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5942X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-03-13+$91,452= $91,452
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-03-13 | +$91,452 | $91,452 | BLOOD DERIVATIVES SOLIRIS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DKCXLGANZAN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24526N0739 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $104,650 | FY2026 |
| 36F79726D0143 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026F0055 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $1,255,805 | FY2026 |
| 36C26025F0093 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $626,866 | FY2025 |
| 36C26024F0096 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $522,487 | FY2024 |
Other recipients under 6507 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA691A10354 | HEMA METRICS, INC. | 262-NETWORK CONTRACT OFFICE 22 | $20,131 | FY2011 |
| VA593C10053 | BAXTER HEALTHCARE CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $302,048 | FY2011 |
| VA664C10143 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 262-NETWORK CONTRACT OFFICE 22 | $46,848 | FY2011 |
| VA593C10009 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 262-NETWORK CONTRACT OFFICE 22 | $132,000 | FY2011 |
| VA664C10012 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 262-NETWORK CONTRACT OFFICE 22 | $56,246 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA691A80359_3600_V797P5942X_3600 · retrieved 2026-09-26.